Significant down-regulation of XRCC4 was found in grade II, III, IV of astrocytoma compared to normal brain tissues and decreased expression of XRCC4 was significantly associated with a poor prognosis (P < 0.05)[34]. Here, XRCC4 is linked to astrocytoma (excluding glioblastoma).